Products Categories
CAS No.: | 1236-99-3 |
---|---|
Name: | Levomepromazine hydrochloride |
Molecular Structure: | |
|
|
Formula: | C19H24N2OS.HCl |
Molecular Weight: | 364.9326 |
Synonyms: | 10H-Phenothiazine-10-propanamine,2-methoxy-N,N,b-trimethyl-,monohydrochloride, (R)-;10H-Phenothiazine-10-propanamine, 2-methoxy-N,N,b-trimethyl-, monohydrochloride, (bR)- (9CI);Phenothiazine,10-[3-(dimethylamino)-2-methylpropyl]-2-methoxy-, monohydrochloride, (-)-(8CI);(-)-Methotrimeprazine hydrochloride;Levomepromazine hydrochloride;Levomepromazinium chloride;Levopromazine hydrochloride;Methotrimeprazinehydrochloride;Neurocil; |
EINECS: | 214-978-3 |
Boiling Point: | 468 °C at 760 mmHg |
Flash Point: | 236.8 °C |
PSA: | 41.01000 |
LogP: | 5.36260 |
What can I do for you?
Get Best Price
The Levomepromazine hydrochloride, with cas registry number 1236-99-3, has the systematic name of (2R)-3-(2-methoxy-10H-phenothiazin-10-yl)-N,N,2-trimethylpropan-1-amine hydrochloride (1:1). Besides this, it is also called (R)-2-Methoxy-N,N,b-trimethyl-10H-phenothiazine-10-propanamine Hydrochloride. What's more, its EINECS is 214-978-3.
Physical properties about this chemical are: (1)ACD/LogP: 4.94; (2)# of Rule of 5 Violations: 0; (3)#H bond acceptors: 3; (4)#H bond donors: 0; (5)#Freely Rotating Bonds: 5; (6)Polar Surface Area: 41.01 Å2; (7)Flash Point: 236.8 °C; (8)Enthalpy of Vaporization: 73.01 kJ/mol; (9)Boiling Point: 468 °C at 760 mmHg; (10)Vapour Pressure: 6.22E-09 mmHg at 25°C.
You can still convert the following datas into molecular structure:
(1)SMILES: Cl.O(c2cc1N(c3c(Sc1cc2)cccc3)C[C@H](C)CN(C)C)C
(2)InChI: InChI=1/C19H24N2OS.ClH/c1-14(12-20(2)3)13-21-16-7-5-6-8-18(16)23-19-10-9-15(22-4)11-17(19)21;/h5-11,14H,12-13H2,1-4H3;1H/t14-;/m1./s1
(3)InChIKey: ODLGFPIWRAEFAN-PFEQFJNWBU
(4)Std. InChI: InChI=1S/C19H24N2OS.ClH/c1-14(12-20(2)3)13-21-16-7-5-6-8-18(16)23-19-10-9-15(22-4)11-17(19)21;/h5-11,14H,12-13H2,1-4H3;1H/t14-;/m1./s1
(5)Std. InChIKey: ODLGFPIWRAEFAN-PFEQFJNWSA-N
The toxicity data is as follows:
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
mouse | LD50 | intraperitoneal | 135mg/kg (135mg/kg) | Comptes Rendus des Seances de la Societe de Biologie et de Ses Filiales. Vol. 160, Pg. 1852, 1966. | |
mouse | LD50 | intravenous | 75mg/kg (75mg/kg) | BEHAVIORAL: SLEEP | Acta Pharmacologica et Toxicologica. Vol. 19, Pg. 87, 1962. |
mouse | LD50 | oral | 380mg/kg (380mg/kg) | Cesko-Slovenska Farmacie. Vol. 15, Pg. 455, 1966. | |
mouse | LD50 | subcutaneous | 360mg/kg (360mg/kg) | Comptes Rendus des Seances de la Societe de Biologie et de Ses Filiales. Vol. 155, Pg. 1029, 1961. |